Characterization of Russian rabies virus vaccine strain RV-97

Virus Research

Volumn 132, Issue 1-2, 2008, Pages 242-247

  Metlin, A ^a,b,d   Paulin, L ^c   Suomalainen, S ^c   Neuvonen, E ^a   Rybakov, S ^b   Mikhalishin, V ^b   Huovilainen, A ^a  

^a NATL VET AND FOOD RES INSTITUTE   (Finland)

^b Federal Centre for Animal Health (FGI ARRIAH)   (Russian Federation)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Rabies; Sequencing; Vaccine

Indexed keywords

GLYCINE DEHYDROGENASE (DECARBOXYLATING); GUANINE NUCLEOTIDE BINDING PROTEIN; LIVE VACCINE; RABIES VACCINE; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BELARUS; GENE SEQUENCE; KAZAKHSTAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; RABIES VIRUS; RABIES VIRUS 97; RUSSIAN FEDERATION; TECHNIQUE; UKRAINE; VIRUS CHARACTERIZATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; GENOME, VIRAL; JAPAN; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PHYLOGENY; RABIES VACCINES; RABIES VIRUS; RUSSIA; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

RABIES VIRUS;

EID: 39149111243     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.11.016     Document Type: Article

References (33)

1. Arai Y.T., Yamada K., Kameoka Y., Horimoto T., Yamamoto K., Yabe S., Nakayama M., and Tashiro M. Nucleoprotein gene analysis of fixed and street rabies virus variants using RT-PCR. Arch. Virol. 142 (1997) 1787-1796
2. Badrane H., Bahloul C., Perrin P., and Tordo N. Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J. Virol. 75 (2001) 3268-3276
3. Benmansour A., Leblois H., Coulon P., Tuffereau C., Gaudin Y., Flamand A., and Lafay F. Antigenicity of rabies virus glycoprotein. J. Virol. 65 (1991) 4198-4203
4. Borisov A.V., Toloknov A.C., Metlin A.E., Mikhalishin V.V., and Rybakov S.S. Efficacy and safety testing of the viral vaccine "Sinrab" on the targeted species. Sci. Notes Vitebsk State Acad. Vet. Med. 38 (2002) 15-18
5. Botvinkin A.D., Poleschuk E.M., Kuzmin I.V., Borisova T.I., Gazaryan S.V., Yanger P., and Rupprecht C.E. Novel Lyssaviruses isolated from bats in Russia. Emerg. Infect. Dis. 9 (2003) 1623-1625
6. Bourhy H., Tordo N., Lafon M., and Sureau P. Complete cloning and molecular organization of a rabies-related virus, Mokola Virus. J. Gen. Virol. 70 (1989) 2063-2074
7. Bunschoten H., Gore M., Claassen I.J., Uytdehaag F.G., Dietzschold B., Wunner W.H., and Osterhaus A.D. Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. J. Gen. Virol. 70 (1989) 291-298
8. Conzelmann K., Cox J., Schneider L., and Thiel H. Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19. Virology 175 (1990) 485-499
9. Ertl H.C., Dietzschold B., Gore M., Otvos Jr. L., Larson J.K., Wunner W.H., and Koprowski H. Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein. J. Virol. 63 (1989) 2885-2892
10. Faber M., Faber M.L., Papaneri A., Bette M., Weihe E., Dietzschold B., and Schnell M.J. A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity. J. Virol. 79 (2005) 14141-14148
11. Fodor I., Grabko V.I., Khozinski V.V., and Selimov M.A. Nucleotide and deduced amino acid sequences of the glycoprotein gene of rabies virus vaccine strain Vnukovo-32. Arch. Virol. 135 (1994) 451-459
12. Follmann E.H., Ritter D.G., and Baer G.M. Evaluation of the safety of two attenuated oral rabies vaccines, SAG1 and SAG2, in six Arctic mammals. Vaccine 14 (1996) 270-273
13. Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., and Ball L.A. Virus Taxonomy. Classification and Nomenclature of Viruses: The Eighth Report of the International Committee on Taxonomy of Viruses. Part II-The Negative Sense Single Stranded RNA Viruses (2005), Elsevier Academic Press 609-614
14. Gruzdev K.N., and Nedosekov V.V. Rabies of Animals [Book in Russian] (2001), Akvarium, Moscow
15. Hiramatsu K., Mifune K., Mannen K., Nishizono A., Kawano H., Ito Y., and Kawai A. Mapping of the antigenic determinants recognized by monoclonal antibodies against the M2 protein of rabies virus. Virology 187 (1992) 472-479
16. Ito M., Itou T., Sakai T., Santos M.F., Arai Y.T., Takasaki T., Kurane I., and Ito F.H. Detection of rabies virus RNA isolated from several species of animals in Brazil by RT-PCR. J. Vet. Med. Sci. 63 (2001) 1309-1313
17. Johnson N., Mansfield K.L., and Fooks A.R. Canine vaccine recipients recognize and immunodominant region of the rabies virus glycoprotein. J. Gen. Virol. 83 (2002) 2663-2669
18. Kumar S., Tamura K., and Nei M. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief. Bioinf. 5 (2004) 150-163
19. Kuzmin I.V., Hughes G.J., Botvinkin A.D., Orciari L.A., and Rupprecht C.E. Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for Lyssavirus genotype definition. Virus Res. 111 (2005) 28-43
20. Lafon M., Ideler J., and Wunner W.H. Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies. Dev. Biol. Stand. 57 (1984) 219-225
21. Larson J.K., Wunner W.H., Otvos L., and Ertl H. Identification of an immunodominant epitope within the phosphoprotein of rabies virus that is recognized by both class I- and Class II-restricted T cells. J. Virol. 65 (1991) 5673-5679
22. McColl K.A., Tordo N., and Setien A. Bat Lyssavirus infections. Rev. Sci. Tech. Off. Int. Epiz. 19 (2000) 177-196
23. Metlin A., Rybakov S., Gruzdev K., Neuvonen E., and Huovilainen A. Genetic heterogeneity of Russian Estonian and Finnish field rabies viruses. Arch. Virol. 152 (2007) 1645-1654
24. Pastoret P.P., and Brochier B. Epidemiology and control of fox rabies in Europe. Vaccine 17 (1999) 1750-1754
25. Prehaud C., Coulon P., Lafay F., Thiers C., and Flamand A. Antigenic site II of the rabies virus glycoprote: structure and role in viral virulence. J. Virol. 62 (1988) 1-7
26. Seif I., Coulon P., Rollin P.E., and Flamand A. Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J. Virol. 53 (1985) 926-934
27. Shimizu K., Ito N., Mita T., Yamada K., Hosokawa-Muto J., Sugiyama M., and Minamoto N. Involvement of nucleoprotein, phosphoprotein, and matrix protein genes of rabies virus in virulence for adult mice. Virus Res. 123 (2007) 154-160
28. Staden R., Beal K.F., and Bonfield J.K. The Staden package, 1998. Meth. Mol. Biol. 132 (2000) 115-130
29. Takayama-Ito M., Ito N., Yamada K., Sugiyama M., and Minamoto N. Multiple amino acids in the glycoprotein of rabies virus are responsible for pathogenicity in adult mice. Virus Res. 115 (2006) 169-175. (Epub 2005 September 26)
30. Tordo N., Poch O., Ermine A., Keith G., and Rougeon F. Walking along the rabies genome: is the large G-L intergenic region a remnant gene?. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 3914-3918
31. Tordo N. Characteristics and molecular biology of rabies virus. In: Meslin F.X., Kaplan M.M., and Koprowski H. (Eds). Laboratory Techniques in Rabies (1996), WHO, Geneva 28-51
32. Vos A., Muller T., Schuster P., Schluter H., and Neuber A. Oral vaccination of foxes against rabies with SAD B19 in Europe, 1983-1998: a review. Vet. Bull. 70 (2000) 1-6
33. Yi C.E., Ba L., Zang L., Ho D.D., and Chen Z. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain. J. Virol. 79 (2005) 11638-11646